Literature DB >> 33822804

Normative values of the vibration perception thresholds at finger pulps and metatarsal heads in healthy adults.

Linnéa Ekman1, Eero Lindholm2, Elisabeth Brogren3, Lars B Dahlin1,3.   

Abstract

AIMS: To establish normative values of vibration perception thresholds (VPTs), using multi-frequency vibrometry at finger pulps and at metatarsal heads of the foot in healthy adults. We also aimed to investigate factors that could potentially affect VPTs such as age, sex, height, weight, foot- or handedness and skin temperature.
METHODS: VPTs were examined in 924 healthy and randomly selected subjects in the southern Sweden (mean 46 years; 628 women and 296 men). Inclusion criterias were adult subjects (>18 years) in considerable health without diabetes mellitus or other nerve affecting disorders. VPTs were measured at the finger pulps of index and little finger, as well as the first and fifth metatarsal heads of the foot, through multi-frequency vibrometry using the VibroSense Meter® I device. Patient characteristics were recorded and skin temperature was measured before assessment of VPTs.
RESULTS: We present normative values of VPTs for a large population of both male and female subjects in various ages. VPTs detoriated as age increased (0.09-0.59 dB per year; p<0.001), i.e. progressing with normal aging. Increasing skin temperature affected VPTs in finger pulps, but not at metatarsal heads, with -0.2 to -1.6 dB, i.e. vibration perception improved with higher temperatures. Height was only found to affect the VPTs of metatarsal heads (250 Hz: 0.42 dB per cm). Sex, weight and handedness did not affect the VPTs.
CONCLUSION: We investigated the normative values of VPTs and presented affecting factors as age, skin temperature and height. With these results, VPT testing through multi-frequency vibrometry is enabled to be used in a clinical practice as a diagnostic tool when investigating neuropathy and other neurological disorders.

Entities:  

Year:  2021        PMID: 33822804     DOI: 10.1371/journal.pone.0249461

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  3 in total

1.  Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy.

Authors:  Sebastian W Nielsen; Simone Dyring Hasselsteen; Helena Sylow Heilmann Dominiak; Dejan Labudovic; Lars Reiter; Susanne Oksbjerg Dalton; Jørn Herrstedt
Journal:  Support Care Cancer       Date:  2022-08-06       Impact factor: 3.359

2.  Peripheral and Autonomic Neuropathy Status of Young Patients With Type 1 Diabetes Mellitus at the Time of Transition From Pediatric Care to Adult-Oriented Diabetes Care.

Authors:  Anna Vágvölgyi; Ágnes Maróti; Mónika Szűcs; Csongor Póczik; Dóra Urbán-Pap; István Baczkó; Attila Nemes; Éva Csajbók; Krisztián Sepp; Péter Kempler; Andrea Orosz; Tamás Várkonyi; Csaba Lengyel
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-27       Impact factor: 5.555

3.  Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes.

Authors:  Sebastian W Nielsen; Sanne Lindberg; Christina Halgaard Bruvik Ruhlmann; Lise Eckhoff; Jørn Herrstedt
Journal:  J Clin Med       Date:  2022-03-27       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.